Hospital
Saint Thomas River Park Hospital, LLC
Saint Thomas River Park Hospital, LLC was paid $8.41M by Medicaid between Jan 2018 and Dec 2024, across 91 billing codes. Its largest line is 99283, emergency room visit (moderate) — 39% of everything it billed.
33Billing provider infoSAINT THOMAS RIVER PARK HOSPITAL, LLC
MCMINNVILLE, TN 37110
MCMINNVILLE, TN 37110
33aNPI1518346469assigned 05/26/2015
33bProvider typeGeneral Acute Care Hospital
28Total paid$8.41M
24GClaims204,675
24DCodes billed91
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Tennessee
Rank by total paid#30 of 71
Median peer was paid$6.96M
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DAVIS, LISA controls 12+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 31,997 | $1.45M | |
| 2019 | 32,873 | $1.35M | |
| 2020 | 25,738 | $1.04M | |
| 2021 | 32,113 | $1.24M | |
| 2022 | 31,814 | $1.25M | |
| 2023 | 37,900 | $1.41M | |
| 2024incomplete | 12,240 | $672K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 39% | 24,793 | 23,155 | $3.25M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 34% | 20,287 | 17,971 | $2.89M |
| G0378 | Hospital observation service, per hour | 7.6% | 2,894 | 2,127 | $640K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.6% | 3,327 | 2,860 | $471K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.9% | 2,206 | 2,105 | $157K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.5% | 3,762 | 3,472 | $128K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.5% | 12,596 | 10,963 | $125K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.5% | 3,812 | 3,503 | $125K |
| 84484 | <1% | 9,795 | 7,436 | $70K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 15,743 | 13,647 | $59K |
| 59025 | Fetal non-stress test | <1% | 989 | 653 | $52K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 13,972 | 11,796 | $49K |
79 more codes
| 80053 | Comprehensive metabolic panel | <1% | 17,786 | $48K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 808 | $41K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,550 | $27K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,228 | $26K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 71 | $26K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,453 | $22K |
| 85027 | <1% | 7,405 | $22K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 928 | $19K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,567 | $19K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 391 | $15K |
| 83690 | <1% | 3,800 | $14K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 149 | $12K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,147 | $12K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,941 | $9K |
| 71045 | Radiologic examination, chest; single view | <1% | 5,374 | $9K |
| 81001 | <1% | 10,866 | $8K | |
| 87070 | <1% | 1,535 | $7K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 942 | $6K |
| 81025 | <1% | 2,061 | $5K | |
| 83880 | <1% | 902 | $5K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 79 | $4K |
| 76830 | Ultrasound, transvaginal | <1% | 72 | $4K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,750 | $3K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 151 | $3K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 155 | $3K |
| 83735 | <1% | 1,343 | $3K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 36 | $2K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 50 | $2K |
| 84112 | <1% | 53 | $2K | |
| 85610 | <1% | 1,591 | $2K | |
| 74018 | <1% | 142 | $2K | |
| 87634 | <1% | 60 | $2K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 99 | $2K |
| 83605 | <1% | 396 | $1K | |
| 0011A | <1% | 44 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 380 | $1K |
| 85730 | <1% | 477 | $1K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 19 | $949.54 |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 14 | $879.82 |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 21 | $859.43 |
| 0012A | <1% | 40 | $796.50 | |
| 76801 | <1% | 14 | $773.52 | |
| 87807 | <1% | 102 | $540.72 | |
| 85379 | <1% | 75 | $519.00 | |
| 81003 | <1% | 763 | $442.37 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 115 | $442.08 |
| 80076 | <1% | 159 | $422.43 | |
| 87040 | <1% | 158 | $394.11 | |
| 82150 | <1% | 93 | $385.07 | |
| 82550 | <1% | 163 | $363.45 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,926 | $360.77 |
| 84703 | <1% | 68 | $355.70 | |
| 86140 | <1% | 135 | $341.36 | |
| 82731 | <1% | 16 | $324.75 | |
| 84702 | <1% | 14 | $137.45 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 35 | $107.10 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 42 | $106.28 |
| 36415 | Collection of venous blood by venipuncture | <1% | 75 | $104.31 |
| 82570 | <1% | 12 | $83.16 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 17 | $79.89 |
| 84550 | <1% | 12 | $69.83 | |
| 80061 | Lipid panel | <1% | 16 | $66.43 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 244 | $42.19 |
| 84156 | <1% | 12 | $36.23 | |
| 84100 | <1% | 18 | $32.37 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 718 | $21.63 |
| 91301 | <1% | 112 | $0.26 | |
| 1160F | 0% | 17 | $0.00 | |
| 1159F | 0% | 17 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 1,314 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 2,457 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 107 | $0.00 |
| J3490 | Unclassified drugs | 0% | 274 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 134 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 97 | $0.00 |
| 3008F | 0% | 16 | $0.00 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 43 | $0.00 |
| 1125F | 0% | 15 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAVIS, LISA (CFO MINISTRY MARKET)
| Provider | Location | Paid |
|---|---|---|
| Saint Thomas West Hospital | Nashville, TN | $7.14M |
| Meeting Milestones Early Intervention Services, LLC | Gaffney, SC | $6.63M |
| Saint Thomas West Hospital | Nashville, TN | $3.68M |
| Saint Thomas Highlands Hospital, LLC | Sparta, TN | $3.33M |
| Public Health Solutions | Brooklyn, NY | $2.10M |
| Nursing and Therapy Services of Colorado INC | Colorado Springs, CO | $1.05M |
| Saint Thomas Hickman Hospital | Centerville, TN | $924K |
| Saint Thomas Stones River Hospital, LLC | Woodbury, TN | $554K |
| Metro Anesthesia, PLLC | Ridgeland, MS | $261K |
| Talking Toddlers LLC | Simpsonville, SC | $16K |
| Royal Paradise Cente LLC | West Palm Beach, FL | $4K |
| Lisa A. Davis, M.D., P.A. | San Antonio, TX | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.